Quickie
Colonel
The shocking thing is that from research studies spike proteins from the vaccines are also found in a number of different types of tissues, even brain tissues in one study.
Coronavirus 2019-2020 thread (no unsubstantiated rumours!)
- Thread starter localizer
- Start date
The shocking thing is that from research studies spike proteins from the vaccines are also found in a number of different types of tissues, even brain tissues in one study.
Quickie
Colonel
Just to put things in better context to my previous comments.
Here is the concluding part of the above study:
]. It can be suggested that at least part of the risk to develop adverse reactions following vaccination with mRNA products depends on the organs/tissues where S protein production occurs, as well as on the total amount produced and on the production time course. For example, it was established long ago that distinct tissues widely differ in the efficiency of protein synthesis, but no one so far assessed whether and to what extent this is relevant for the efficacy and safety of mRNA vaccines [
]. Therefore, we further recommend careful characterization of COVID-19 vaccines with regards to systemic disposition, including organs and tissues where S protein production occurs and interindividual variability in local protein synthesis efficiency, to provide a rational basis for dose individualization and to identify subjects at risk for adverse reactions due to either vaccine-induced S protein production in vulnerable sites, excessive S protein production, or both [
].
Here is the concluding part of the above study:
Concluding remarks and future perspectives
Such considerations as a whole support the possibility that COVID-19 mRNA vaccines under some circumstances induce high and possibly toxic amounts of S protein in organs and tissues, in turn leaking into the circulation. In animal models, it is well established that lipid nanoparticle-carried mRNAs undergo systemic disposition and expression in organs such as liver, skeletal muscle, and lungs []. It can be suggested that at least part of the risk to develop adverse reactions following vaccination with mRNA products depends on the organs/tissues where S protein production occurs, as well as on the total amount produced and on the production time course. For example, it was established long ago that distinct tissues widely differ in the efficiency of protein synthesis, but no one so far assessed whether and to what extent this is relevant for the efficacy and safety of mRNA vaccines [
]. Therefore, we further recommend careful characterization of COVID-19 vaccines with regards to systemic disposition, including organs and tissues where S protein production occurs and interindividual variability in local protein synthesis efficiency, to provide a rational basis for dose individualization and to identify subjects at risk for adverse reactions due to either vaccine-induced S protein production in vulnerable sites, excessive S protein production, or both [
].
Last edited:
Because gen therapy or mRNA has many other application(like fighting different sorts of cancers) then providing a slightly better vaccine compared to older but time proven methods.
Like BlackWindMnt has said, mRNA has plenty of applications outside of antiviral vaccines. The potential for mRNA vaccines in treating cancers is the largest one, as it is particularly easy to tailor a custom-made mRNA treatment for each patient and their cancer. Treating certain genetic conditions is also a potential application, in that the mRNA can be used to directly substitute non functional genes during transcription. Dismissing mRNA vaccines wholesale is ill-advised as it really cannot be understated just how much of leap in progress they are in the field of biotech. The technology around mRNA vaccines offers the capability to directly print out custom-designed proteins. Needless to say that isn't something anybody should want to miss out on.
right tools for the right job. The rapid mutation of the COVID spike protein caused concerns (now proven to be well founded) among Chinese regulators whether vaccines focused only on the spike protein will be sufficiently effective.
China has a large amount of the world's market share when it comes to medical technology. Therefore it is important that companies are developing in all directions, so that they will be ready to take on the next challenge, like they were ready on COVID. For the next breakthrough, mRNA vaccine might be the ideal way of delivery.
antiterror13
Brigadier
Well, some western medias and falun gung media would say in a matter of time that the reason it dropped, because "nobody left in China, most already dead by C19"
It does happen but I don’t think it’s relatively common. It’s very rare to find young seemingly heathy and fit athletes die suddenly from cardiac arrests. and usually it’s from previously undetected congenital condition or other underlying condition.